tirzepatide gastrointestinal side effects compared to semaglutide vs. Semaglutide: Which Weight Loss Medication is Right for You? Semaglutide V Tirzepatide: A 2026

Summary: Retatrutide and tesamorelin are both peptide-based compounds used in metabolic medicine, but retatrutide is an unapproved triple incretin receptor agonist in clinical trials, while tesamorelin is a GHRH analogue licensed in the US for HIV-associated lipodystrophy but unlicensed in the UK

The drugs have been shown in studies to reduce the risk of heart and kidney disease and lower average blood sugar levels in people with type 1 diabetes

Reference: Addressing the risk of ocular complications of GLP-1RAs

We'll explore the science behind GLP-1 and its role in weight loss

Current Research and Findings Some studies have explored the effects of weight management medications like semaglutide in patients undergoing cancer treatment

Step 2: Structured Self-Tracking Keep a diary of your symptoms